Related Experiment Video
Updated: Feb 22, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Associations Among Cardio-Ankle Vascular Index, Carotid Intima-Media Thickness, and Fibroblast Growth Factor-21
T Trakarnvanich1, S Prommool1, S Kurathong1
1Renal Unit, Department of Medicine, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Insights
Cardiovascular disease remains a risk after kidney transplants. Arterial stiffness (CAVI) and fibroblast growth factor-21 (FGF-21) were studied, but only CAVI showed links to carotid intima-media thickness and hemoglobin.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in chronic kidney disease (CKD) patients, persisting even post-renal transplantation.
- Cardio-ankle vascular index (CAVI) measures arterial stiffness, while fibroblast growth factor-21 (FGF-21) may indicate atherosclerotic disease.
- This study explored the relationship between CAVI, FGF-21, carotid intima-media thickness (IMT), and other cardiovascular risk factors in renal transplant recipients.
Purpose of the Study:
- To investigate the association between CAVI and FGF-21 in renal transplant patients.
- To examine the relationship of CAVI and FGF-21 with carotid intima-media thickness (IMT).
- To assess correlations with other cardiovascular risk factors.
Main Methods:
- The study included 90 renal transplant patients.
- Data collected included CAVI, echocardiograms, homocysteine, high-sensitivity C-reactive protein, carotid IMT, FGF-21, and CVD incidence.
- Statistical correlation analyses were performed.
Main Results:
- CAVI was higher in older patients and correlated positively with carotid IMT and negatively with hemoglobin.
- No association was found between CAVI and FGF-21 or other parameters.
- FGF-21 correlated positively with high-sensitivity C-reactive protein and negatively with renal function.
- Higher body mass index and carotid IMT were linked to increased cardiovascular events.
Conclusions:
- Cardiovascular risk factors persist after renal transplantation, irrespective of arterial stiffness.
- Close cardiac monitoring and risk-factor modification are essential post-transplantation.
- The study highlights the ongoing need for cardiovascular surveillance in renal transplant recipients.
Background:
Cardiovascular disease is the major cause of death in patients with chronic kidney disease, even after renal transplantation. Cardio-ankle vascular index (CAVI) provides an indicator of arterial stiffness, whereas fibroblast growth factor-21 (FGF-21) levels may provide a biomarker for atherosclerotic disease. We investigated the association between CAVI and FGF-21 and their relationships to carotid intima-media thickness (IMT) and other cardiovascular risk factors.
Methods:
This study included 90 renal transplant patients. Data on CAVI, echocardiograms, homocysteine, high-sensitivity C-reactive protein, carotid IMT, FGF-21, and incidence of cardiovascular disease were collected and correlations were analyzed statistically.
Results:
The mean CAVI was 7.51 ± 1.69. CAVI was significantly higher in older patients (mean age, 51.54 ± 9.92 vs 42.92 ± 11.20 years, P < .001) and was positively correlated with carotid IMT (r = 0.214, P = .050) and negatively with hemoglobin (r = -0.219, P = .044). There was no association between CAVI and FGF-21 or other parameters. FGF-21 was positively correlated with high-sensitivity C-reactive protein and negatively with renal function. The mean carotid IMT score was 0.57 ± 0.18. Scores were significantly higher in patients >60 years of age, with low cholesterol and high-density lipoprotein and high body mass index. Higher body mass index (P = .013) and carotid IMT (P < .001) were associated with more frequent cardiovascular events. Mean homocysteine levels remained >15 μmol/L and did not differ in those with or those without cardiac events.
Conclusions:
This study demonstrates that cardiovascular risk factors remain after renal transplantation, despite normal arterial stiffness. Close cardiac monitoring and risk-factor modification are therefore recommended, even after successful renal transplantation.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Hemodialysis I: Introduction
Regulation of Angiogenesis and Blood Supply

